Literature DB >> 12754700

Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms.

Paula J Bray1, Richard G H Cotton.   

Abstract

Glucocorticoid (GC) resistance can occur in a number of diseases. It can be either generalized (i.e., familial glucocorticoid resistance) or localized (i.e., asthma). In many cases, a reason for this resistance to steroids lies with mutations or polymorphisms present in the glucocorticoid receptor gene (GR/NR3C1) that belongs to a large family of nuclear receptors. A number of GC-resistant cell lines have been isolated in vitro, some of which arose or may have arisen in vivo. These and the mutations defined in them are included in this review as well as mutations engineered in plasmids and expressed in vitro. It also lists polymorphisms and the individual studies where association-related studies have been performed. NR3C1 is located on chromosome 5q31 and contains 10 exons that code for a 777 amino acid protein. There are two naturally occurring isoforms of the NR3C1, GRalpha (functional) and GRbeta (no hormone-binding ability). A total of 15 missense, three nonsense, three frameshift, one splice site, and two alternative spliced mutations have been reported in the NR3C1 gene associated with glucocorticoid resistance as well as 16 polymorphisms. Mutation and polymorphism data for NR3C1 will soon be found on the newly created locus-specific database. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754700     DOI: 10.1002/humu.10213

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  50 in total

1.  Thermodynamic dissection of the intrinsically disordered N-terminal domain of human glucocorticoid receptor.

Authors:  Jing Li; Hesam N Motlagh; Carolyn Chakuroff; E Brad Thompson; Vincent J Hilser
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

Review 2.  Genetics of human aggressive behaviour.

Authors:  Ian W Craig; Kelly E Halton
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

3.  Genetic mapping with multiple levels of phenotypic information reveals determinants of lymphocyte glucocorticoid sensitivity.

Authors:  Joseph C Maranville; Shaneen S Baxter; David B Witonsky; Meredith A Chase; Anna Di Rienzo
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

4.  The NR3C1 Glucocorticoid Receptor Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in Asthma Patients.

Authors:  Michał Panek; Tadeusz Pietras; Artur Fabijan; Jan Zioło; Łukasz Wieteska; Beata Małachowska; Wojciech Fendler; Janusz Szemraj; Piotr Kuna
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

5.  Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.

Authors:  X Wang; P Chen; Y Sun; Y Chen; M Mao; T Jiang; J Ouyang
Journal:  Clin Transl Oncol       Date:  2017-04-25       Impact factor: 3.405

Review 6.  The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease.

Authors:  A Sasha Tait; Cherie L Butts; Esther M Sternberg
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

7.  Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome.

Authors:  Grzegorz Zalewski; Anna Wasilewska; Walentyna Zoch-Zwierz; Lech Chyczewski
Journal:  Pediatr Nephrol       Date:  2008-03-15       Impact factor: 3.714

8.  Pharmacogenomic approaches to asthma treatment.

Authors:  Sang-Heon Cho
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-19       Impact factor: 5.764

9.  Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.

Authors:  Boyko Kabakchiev; Dan Turner; Jeffrey Hyams; David Mack; Neal Leleiko; Wallace Crandall; James Markowitz; Anthony R Otley; Wei Xu; Pingzhao Hu; Anne M Griffiths; Mark S Silverberg
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

10.  Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease.

Authors:  Jan B Egan; K Martin Kortuem; Ahmet Kurdoglu; Tyler Izatt; Jessica Aldrich; Rebecca Reiman; Lori Phillips; Angela Baker; Chang-Xin Shi; Jessica Schmidt; Winnie S Liang; David W Craig; John D Carpten; A Keith Stewart
Journal:  Br J Haematol       Date:  2013-03-11       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.